McKesson to Offer Proventys' Personalized Medicine Service | GenomeWeb
This article has been updated to include comments from a McKesson official.
 
NEW YORK (GenomeWeb News) – McKesson today announced that it would offer a personalized medicine knowledge service developed by privately held Proventys.
 
Durham, NC-based Proventys translates predictive data from traditional and emerging diagnostic tests — including genomics, proteomics, and metabolomics — into clinical decision support products.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.